Subsequent mechanism experiments showed that increased circ‐CMPK1 could directly interact with miR‐302e and functioned as a ceRNA to elevate oncogenic cyclin D1 expression by inhibiting miR‐302e activity, thereby promoting the progression of NSCLC. Here, CMPK1 is linked to non-small cell lung carcinoma.